![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » Moderna’s COVID-19 Vaccine Wins Canadian Approval
Moderna’s COVID-19 Vaccine Wins Canadian Approval
![Canada flag](https://www.fdanews.com/ext/resources/test/Drug-Images4/Canada_Flag.gif?t=1627934481&width=430)
December 29, 2020
Health Canada has authorized Moderna’s messenger RNA-based COVID-19 vaccine for emergency use for adults 18 years and older.
The Dec. 23 decision followed Canada’s conditional approval for the Pfizer/BioNTech vaccine on Dec. 9. Both vaccines demonstrated 95 percent efficacy in late-stage clinical trials.
Earlier this month, Canada exercised its option to purchase an additional 20 million doses of the Moderna vaccine, bringing its total order to 40 million doses.
Upcoming Events
-
21Oct